-
May 15, 2024, 11:36 am263 ptsTopGreen Market Report
Clinical-stage biopharmaceutical firm Alto Neuroscience Inc. (NYSE: ANRO) gave a business update alongside its first quarter 2024 financials ending March 31. Alto reported cash and equivalents of $205.9 million at the end of March, expected to fund operations into 2027. R&D expenses rose to $10 million from…
Trending Today on NewsBudz
NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.
Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.